Evidence map›Paper›PMID 38633946›Full record

ArticleCureus2024

The Impact of Congestive Heart Failure on Outcomes in Patients Hospitalized With Preeclampsia.

Omar Elkattawy, Saahil Patel, Javier Montoya, Kanzah Sarfaraz, Sedra Alabed, Omar Gobji, Sherif Elkattawy, Jesus Romero, Fayez Shamoon

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Omar ElkattawyInternal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Saahil PatelInternal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Javier MontoyaInternal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Kanzah SarfarazInternal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Sedra AlabedInternal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Omar GobjiInternal Medicine, New York Medical College, Valhalla, USA.
Sherif ElkattawyCardiology, St. Joseph's University Medical Center, Paterson, USA.
Jesus RomeroInternal Medicine, Trinitas Regional Medical Center, Elizabeth, USA.
Fayez ShamoonCardiology, St. Joseph's University Medical Center, Paterson, USA.
New York Medical College · USRutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · USSt. Joseph’s University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe purpose of this study was to determine the prevalence of congestive heart failure (CHF) among patients admitted with preeclampsia as well as to analyze the independent association of CHF with in-hospital outcomes among women with preeclampsia.

methodsData were obtained from the National (Nationwide) Inpatient Sample (NIS) from January 2016 to December 2019. We assessed the independent association of CHF with outcomes in patients admitted with preeclampsia. Predictors of mortality in patients admitted with preeclampsia were also analyzed.

resultsWomen with preeclampsia in the United States between 2016 and 2019 were included in our analysis. A total of 256,010 cases were isolated, comprising 1150 patients with preeclampsia and CHF (0.45%). Multivariate analysis demonstrated that CHF in patients with preeclampsia was independently associated with several outcomes, among them cardiac arrest (adjusted OR (aOR) 4.635, p=0.004), ventricular tachycardia (aOR 17.487, p<0.001), pulmonary embolism (aOR 6.987, p<0.001), and eclampsia (aOR 2.503, p=0.011). Conversely, we found CHF to be protective against postpartum hemorrhage (aOR 0.665, p=0.003). Among the predictors of mortality in preeclampsia are age (aOR 1.062, p=0.022), Asian or Pacific Islander race (aOR 4.695, p=0.001), and CHF (aOR 25.457, p<0.001).  Conclusions: In a large cohort of patients admitted with preeclampsia, we found the prevalence of CHF to be 0.45%. CHF was associated with several adverse outcomes as well as increased length of stay.

Indexed as

cardio-obstetricscongestive heart faiulreheart disease in pregnancyhigh-risk pregnancypreeclampsia

Identifiers

PMID38633946
PMCPMC11022979
OpenAlexW4392908635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.